References
- Serra HM, Holopainen JM, Beuerman R, et al. Climatic droplet keratopathy: an old disease in new clothes. Acta Ophthalmol. 2015;93:496–504.
- Suarez MF, Piqueras MC, Correa L, et al. phospholipidomic studies in human cornea from climatic droplet keratopathy. J Cell Biochem. 2017;118:3920–3931.
- Suárez MF, Correa L, Crim N, et al. Climatic droplet keratopathy in Argentina: involvement of environmental agents in its genesis which would open the prospect for new therapeutic interventions. Biomed Res Int. 2015;1–9.
- Ormerod LD, Dahan E, Hagele JE, et al. Serious occurrences in the natural history of advanced climatic keratopathy. Ophthalmology. 1994;101:448–453.
- Holopainen JM, Robciuc A, Cafaro TA, et al. Pro-inflammatory cytokines and gelatinases in climatic droplet keratopathy. Invest Ophthalmol Vis Sci. 2012;53:3527–3535.
- Schurr TG, Dulik MC, Cafaro TA, et al. Genetic background and climatic droplet keratopathy incidence in a mapuche population from Argentina. PLoS ONE. 2013;8:e74593.
- Fraunfelder FT, Hanna C. Spheroidal degeneration of cornea and conjunctiva. 3: incidence, classification and etiology. Am J Ophthalmol. 1973;76:41–50.
- Freedman A. Labrador keratopathy. Arch Ophthalmol. 1965;74:198–202.
- Urrets-Zavalia JA, Maccio JP, Knoll EG, et al. Surface alterations, corneal hypoesthesia, and iris atrophy in patients with climatic droplet keratopathy. Cornea. 2007;26:800–804.
- Gray RH, Johnson GJ, Freedman A. Climatic Droplet Keratopathy. Surv Ophthalmol. 1992;36:241–253.
- Resnikoff S, Filliard G, Dell’Aquila B. Climatic droplet keratopathy, exfoliation syndrome, and cataract. Br J Ophthalmol. 1991;75:734–736.
- Callus CA, Vella S, Ferry P. Scurvy is Back. Nutr Metab Insights. 2018;11:1–2.
- United States Food and Drug Administration. Cenegermin-bkbj package insert. [cited 2021 Dec 28]. https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/761094s000lbl.pdf